Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGVP.L Regulatory News (GVP)

  • There is currently no data for GVP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Open Letter to Associated Capital Group, Inc.

15 Oct 2020 17:46

Metage Capital Limited - Open Letter to Associated Capital Group, Inc.

Metage Capital Limited - Open Letter to Associated Capital Group, Inc.

PR Newswire

London, October 15

Metage Capital Limited: open letter to Associated Capital Group, Inc.

Mr Bruce LismanAssociated Capital Group, Inc.191 Mason StreetGreenwich, CT 06830

For Immediate Release

15th October 2020

Dear Mr Lisman,

Re: respecting the vote by shareholders to discontinue the Gabelli Value Plus+ Trust Plc. (“GVP”)

On 6th October 2020 you held a webinar setting out the position of Associated Capital Group, Inc. (“ACG”) on the continuation of GVP. When signing up to this webinar, investors were asked to submit questions, however none were addressed. We have been dissatisfied by the subsequent response from ACG to the questions that we asked and believe that other shareholders would share similar queries. We therefore ask you to respond publicly to the following:

1. In the GVP announcement of 6th October, the Board of GVP refers to “…a letter received by the Board from the general counsel to ACG on 2 October 2020 indicating that (unspecified) litigation concerning the company may be a distinct possibility…” Can you please explain why ACG is threatening legal action, what potential illegality or breach of contract you perceive and what the aim of this litigation would be?

2. The “Magna Carta of shareholder Rights” on Gabelli Investors, Inc.’s website[1] states that it is in favour of “one share: one vote” and that “…we will vote against…supermajority voting…” How is attempting to frustrate the will of a clear majority of shareholders consistent with Gabelli’s corporate governance principles?

3. The Board has offered the potential of an in specie redemption of ACG’s pro rata share of the GVP portfolio or the ability to provide ACG with a roll over vehicle with a similar strategy and manager. This would enable ACG to continue its investment without frustrating the desire of other shareholders for a cash exit. How would you justify attempting to trap the majority of shareholders against their will?

Finally we would like to thank the Board of GVP for their steadfastness in a difficult situation, which is an excellent demonstration of the highest standards of corporate governance in London-listed investment trusts.

Yours faithfully,Tom Sharp, DirectorMetage Capital LimitedPrinces House, 38 Jermyn Street, London SW1Y 6DN, United KingdomEmail: tom.sharp@metage.comTel: +(44) 203 813 8590

[1] https://www.gabelli.co.uk/wp-content/uploads/2015/01/magnacarta092403.pdf

Date   Source Headline
7th Aug 202012:14 pmRNSDirectorate Change - Appointment of Audit Chair
7th Aug 20209:00 amRNSNet Asset Value(s)
6th Aug 20209:02 amRNSNet Asset Value(s)
6th Aug 20208:56 amRNSHolding(s) in Company
5th Aug 202012:45 pmRNSNet Asset Value(s)
4th Aug 20209:32 amRNSNet Asset Value(s)
3rd Aug 20209:00 amRNSNet Asset Value(s)
31st Jul 202012:45 pmRNSNet Asset Value(s)
30th Jul 20205:24 pmRNSResult of AGM
30th Jul 202010:35 amRNSNet Asset Value(s)
29th Jul 20209:00 amRNSNet Asset Value(s)
28th Jul 202011:10 amRNSNet Asset Value(s)
27th Jul 202011:24 amRNSNet Asset Value(s)
24th Jul 20209:00 amRNSNet Asset Value(s)
23rd Jul 202010:26 amRNSNet Asset Value(s)
22nd Jul 20209:00 amRNSNet Asset Value(s)
21st Jul 20204:47 pmRNSPress Release by Associated Capital Group
21st Jul 20209:57 amRNSNet Asset Value(s)
20th Jul 20209:00 amRNSNet Asset Value(s)
17th Jul 20201:39 pmRNSHolding(s) in Company
17th Jul 20209:00 amRNSNet Asset Value(s)
16th Jul 202011:14 amRNSNet Asset Value(s)
15th Jul 20201:51 pmRNSHolding(s) in Company
15th Jul 20209:00 amRNSNet Asset Value(s)
14th Jul 20209:15 amRNSNet Asset Value(s)
13th Jul 202011:38 amRNSNet Asset Value(s)
10th Jul 202010:16 amRNSNet Asset Value(s)
9th Jul 202010:22 amRNSNet Asset Value(s)
8th Jul 20209:00 amRNSNet Asset Value(s)
7th Jul 20204:17 pmRNSAnnual Financial Report
7th Jul 20209:43 amRNSNet Asset Value(s)
7th Jul 20207:00 amRNSLetter to Shareholders
6th Jul 20203:07 pmRNSQuarterly Disclosure as at 30.06.2020
6th Jul 20209:43 amRNSNet Asset Value(s)
3rd Jul 20209:22 amRNSNet Asset Value(s)
2nd Jul 20204:18 pmRNSHolding(s) in Company
2nd Jul 202010:35 amRNSNet Asset Value(s)
2nd Jul 202010:02 amRNSLetters to Shareholders
1st Jul 20205:06 pmRNSFinal Results
1st Jul 20209:33 amRNSNet Asset Value(s)
30th Jun 20209:38 amRNSNet Asset Value(s)
29th Jun 20209:00 amRNSNet Asset Value(s)
26th Jun 202012:26 pmRNSNet Asset Value(s)
25th Jun 20209:00 amRNSNet Asset Value(s)
24th Jun 20209:00 amRNSNet Asset Value(s)
23rd Jun 202010:20 amRNSNet Asset Value(s)
22nd Jun 202010:22 amRNSNet Asset Value(s)
19th Jun 20209:06 amRNSNet Asset Value(s)
18th Jun 20209:00 amRNSNet Asset Value(s)
17th Jun 20209:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.